SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Playing the QQQQ with Terry and friends. -- Ignore unavailable to you. Want to Upgrade?

To: Walkingshadow who wrote (246)5/19/2005 6:10:06 PM
From: MJ  Read Replies (1) | Respond to of 4814
 
Terry

Ironic. Should follow my intuition---looked at it this a.m. and almost bought.

Did see an article that indicated STem's loss had widened. Felt skeptical about buying in again. At least daughter still has----told her to hold.

mj



To: Walkingshadow who wrote (246)5/20/2005 8:15:44 AM
From: Slagle  Read Replies (1) | Respond to of 4814
 
Terry, Re: STEM flying. So is VRTX, they have a med for hepatitis C that did very well in a small phase one trial in Europe. They wil file with the FDA for phase 2 trials here maybe later this year. May 17 webcast is interesting. As far as I know this put them at the head of the pack with a protease inhibitor.
Slagle


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News